An Open-Label, Long-Term Study of Telmisartan Plus Amlodipine Fixed-Dose Combination.
Phase of Trial: Phase III
Latest Information Update: 12 Dec 2013
At a glance
- Drugs Amlodipine/telmisartan (Primary)
- Indications Essential hypertension
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 21 Dec 2012 Results from this trial have been reported in an Astellas Pharma and Boehringer Ingelheim Nippon media release.
- 13 Oct 2010 A Boehringer Ingelheim media release states the EMEA has approved telmisartan/amlodipine for the treatment of hypertension in adults.
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.